Cargando…
CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics
Genome editing allows for the precise manipulation of DNA sequences in a cell making this technology essential for understanding gene function. CRISPR/Cas9 is a targeted genome-editing platform derived from bacterial adaptive immune system and has been repurposed into a genome-editing tool. The RNA-...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325665/ https://www.ncbi.nlm.nih.gov/pubmed/30636933 http://dx.doi.org/10.1186/s12935-019-0726-0 |